GENEO Capital Entrepreneur brings together a group of long-term investors to support Actéo in its growth and the evolution of its governance.

GENEO Capital entrepreneur supports the Actéo group, which specializes in the manufacture (Théolaur) and distribution of paints and complementary products for the building industry (Théodore Maison de Peinture), in the evolution of its capital with a view to accelerating its development projects, notably around innovation, its low-carbon approach and digital. This transaction is part of a long-term, positive-impact investment strategy.

The HOPPEN Group announces that Après-demain SA has joined its investors Extens and Geneo in acquiring a stake in the company.

After 4 years marked by accelerated organic and external growth, HOPPEN has established itself as the French leader in phygital support for patients and healthcare establishments, reducing the workload of caregivers.

A benchmark player in its market and recently nominated for the French Tech 2030 award, the company is taking a new step forward with the acquisition of a stake in Après-demain SA, the parent company of Debiopharm™, a life sciences company, to accelerate its growth plan in Europe and consolidate its market leadership in digital solutions for patients before, during and after hospitalization.

GENEO Capital Entrepreneur reports record results in 2022

Founded in 2019 by Fanny Letier and François Rivolier, GENEO Capital Entrepreneur currently manages over €600 million through three investment vehicles offering French companies, European leaders in their field, a wide range of financial products to support their growth over the long term.

Manifesto - Human Impact Index

Created in 1989, the Scutum Group has become one of the leaders in safety and security in Europe, providing technological solutions for protection and risk prevention, particularly through turnkey services for security, remote surveillance and fire detection.